novidades científicas Novo

16:13 European Cardiovascular Disease Statistics 2017
10:47 CETP inhibitor meets primary endpoint in CV outcome study
9:54 Arrhythmias and devices
14:31 Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
14:18 Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Safety – the big challenge for oral anticoagulants

20 Setembro 2016

Raffaele De Caterina
“G. d’Annunzio” University – Chieti and “G- Monasterio” Foundation – Pisa, Italy

Bioelectronic Medicine. Challenging the future

20 Setembro 2016
0

Sleep apneia and new devices

20 Setembro 2016
0

-->